Baillie Gifford’s Nduka Amadi explores how rare disease innovations are reshaping global health, offering new treatments and long-term value creation. Capital at risk.
Investing for positive change
More Articles
-
SAINTS spotlight: still a ‘wicked learning environment’
Baillie Gifford
10 November 2025
-
Japan small caps: where obsession meets opportunity
Baillie Gifford
31 October 2025
-
Scottish Mortgage Portfolio Update Q3 2025
Baillie Gifford
27 October 2025
-
Monks’ musings: the fruits of resilience and diversity
Baillie Gifford
23 October 2025
-
Bringing it home: the companies winning from deglobalisation
Baillie Gifford
22 October 2025
Editor's Picks
Loading...
